Abstract:Objective To observe the effect of butyrate on the balance of T helper cell ( Th) one , Th2 and Th17 -type cytokines in the colon of dextran sulphate sodium salt ( DSS ) -induced colitic mice. Methods Eighty male Balb/c mice was randomly divided into four groups as below:normal group , model group , blank group and test group.A murine model of DSS-induced colitis was induced among mo-del group, blank group and test group.After treatment of DSS, butyrate (100 mg? kg -1? d -1 , 0.2 mL) was used in test group by intragastric administration once a day for 7 d.The weight , survival rate and length of colon were evaluated.The production of Th1 ( interleukin -4, IL-6, IL-10 ) , Th2[ tumor necrosis factor-α( TNF-α);inferon-γ( IFN-γ) ,IL-17 ] and Th17-type cytokines ( IL-17 ) was detected by enzyme -linked immunosorbent assay .The pathological change of colon was observed by light microscope with HE staining . The pathological grade was evaluated . Results Compared with normal group , the weight of mice and the length of colon in model group were significantly de-creased ( P<0.05 ).The expression of cytokines was increased .Compared with blank group , the weight of mice and the length of colon in test group were increased ( P<0.05 ) and the survival rate rised ( test group:70%, blank group:50%) . Compared with blank group , Th1, Th2 and Th17 -type cytokines in test group were deceased:(367.89 ±29.83 ) vs ( 693.49 ±228.77 ) pg? mL-1 , ( 256.29 ±34.18 ) vs ( 704.49 ±179.00 ) pg? mL-1 , (392.44 ±28.70 ) vs ( 992.34 ±159.93 ) pg? mL-1 , ( 361.81 ±63.39 ) vs ( 816.31 ±204.00 ) pg? mL-1 , (302.43 ±42.59 ) vs ( 527.58 ±152.27 ) pg? mL-1 , ( 250.10 ±36.15 ) vs ( 400.16 ±118.28 ) pg? mL -1 ( all P<0.05).It is near to those in normal group.The ratios of IL-4, IL-6, IL-10, TNF-α, IFN-γand IL-17 between test and normal group were 1.94, 1.51, 1.62, 1.13, 1.34 and 1.31, respectively.The pathological grade all the mice in model group got to the level above II .The percentage of mice in blank group and test group that below the grade of Ⅱwere 38.5% and 71.0%, which meant the pathological change in test group was better than that in blank group.Conclusion Butyrate could promote remission of colitis in mice by keeping the balance of Th 1, Th2 and Th17-type cytokines.

Butyrate Inhibits Interleukin-17 and Generates Tregs to Ameliorate Colorectal Colitis in Rats

Microbiota Metabolite Butyrate Differentially Regulates Th1 and Th17 Cells’ Differentiation and Function in Induction of Colitis

Butyrate Attenuates Intestinal Inflammation in Crohn’s Disease by Suppressing Pyroptosis of Intestinal Epithelial Cells Via the Cgsa-Sting-nlrp3 Axis

P036 Faecalibacterium Prausnitzii Produces Butyrate to Maintain Th17/Treg Balance and to Ameliorate Colorectal Colitis by Inhibiting Histone Deacetylase 1

Butyrate Induces Intestinal Epithelial Cell to Express Thrombospondin 1 and Suppress Intestinal Mucosal Inflammation

Butyrate Prevents the Pathogenic Anemia‐Inflammation Circuit by Facilitating Macrophage Iron Export

Butyrate Functions in Concert with Myeloid-Derived Suppressor Cells Recruited by CCR9 to Alleviate DSS-induced Murine Colitis.

Microbiota metabolite butyrate constrains neutrophil functions and ameliorates mucosal inflammation in inflammatory bowel disease

Butyrate alleviates murine colitis by promoting the expansion of myeloid-derived suppressor cells

P036 Microbiota Metabolite Butyrate Attenuates Intestinal Inflammation Through Autophagy Activation

Faecalibacterium Prausnitzii Inhibits Interleukin-17 to Ameliorate Colorectal Colitis in Rats

Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells

Effects of sodium butyrate on the balance of inflammation -related cytokines in colitic mice

Resveratrol modulates the gut microbiota to prevent murine colitis development through induction of Tregs and suppression of Th17 cells

Sodium Butyrate Reduces Colitogenic Immunoglobulin A-Coated Bacteria and Modifies the Composition of Microbiota in IL-10 Deficient Mice

Roseburia intestinalis and Its Metabolite Butyrate Inhibit Colitis and Upregulate TLR5 through the SP3 Signaling Pathway

Butyrate enhances CPT1A activity to promote fatty acid oxidation and iTreg differentiation

Butyrate Inhibits the HDAC8/NF-κB Pathway to Enhance Slc26a3 Expression and Improve the Intestinal Epithelial Barrier to Relieve Colitis

Stigmasterol Restores the Balance of Treg/Th17 Cells by Activating the Butyrate-PPARγ Axis in Colitis

Tannic acid protects against colitis by regulating the IL17 - NFκB and microbiota - methylation pathways

Tu2022 Faecalibacterium prausnitzii Supernatant Ameliorates DSS-Induced Colitis by Regulating Th17 Cells Differentiation